| Leptin and obesity: role and clinical implication M Obradovic, E Sudar-Milovanovic, S Soskic, M Essack, S Arya, ... Frontiers in endocrinology 12, 585887, 2021 | 573 | 2021 |
| Link between metabolic syndrome and insulin resistance Z Gluvic, B Zaric, I Resanovic, M Obradovic, A Mitrovic, D Radak, ... Current vascular pharmacology 15 (1), 30-39, 2017 | 229 | 2017 |
| Homocysteine and hyperhomocysteinaemia BL Zaric, M Obradovic, V Bajic, MA Haidara, M Jovanovic, ER Isenovic Current medicinal chemistry 26 (16), 2948-2961, 2019 | 226 | 2019 |
| Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure SS Soskić, BD Dobutović, EM Sudar, MM Obradović, DM Nikolić, ... The open cardiovascular medicine journal 5, 153, 2011 | 210 | 2011 |
| Resistin: an inflammatory cytokine. Role in cardiovascular diseases, diabetes and the metabolic syndrome N Abate, H S Sallam, M Rizzo, D Nikolic, M Obradovic, P Bjelogrlic, ... Current pharmaceutical design 20 (31), 4961-4969, 2014 | 126 | 2014 |
| Glutathione “redox homeostasis” and its relation to cardiovascular disease VP Bajic, C Van Neste, M Obradovic, S Zafirovic, D Radak, VB Bajic, ... Oxidative medicine and cellular longevity 2019, 2019 | 122 | 2019 |
| PCSK9 inhibition-a novel mechanism to treat lipid disorders? M Banach, M Rizzo, M Obradovic, G Montalto, J Rysz, D P Mikhailidis, ... Current pharmaceutical design 19 (21), 3869-3877, 2013 | 78 | 2013 |
| MicroRNA in breast cancer: the association with BRCA1/2 N Petrovic, R Davidovic, V Bajic, M Obradovic, RE Isenovic Cancer Biomarkers 19 (2), 119-128, 2017 | 65 | 2017 |
| Benefits of L-arginine on cardiovascular system E Sudar-Milovanovic, M Obradovic, A Jovanovic, B Zaric, S Zafirovic, ... Mini Reviews in Medicinal Chemistry 16 (2), 94-103, 2016 | 47 | 2016 |
| Role of C-reactive protein in diabetic inflammation J Stanimirovic, J Radovanovic, K Banjac, M Obradovic, M Essack, ... Mediators of inflammation 2022, 2022 | 46 | 2022 |
| TNF-α-308 promotor polymorphism in patients with chronic obstructive pulmonary disease and lung cancer L NAGORNI, MM OBRADOVIC, DR MILIKIC Neoplasma 56, 4, 2009 | 44 | 2009 |
| Peroxisome proliferator-activated receptors and atherosclerosis SS Soskić, BD Dobutović, EM Sudar, MM Obradović, DM Nikolić, BL Zarić, ... Angiology 62 (7), 523-534, 2011 | 43 | 2011 |
| A high fat diet induces sex-specific differences in hepatic lipid metabolism and nitrite/nitrate in rats J Stanimirovic, M Obradovic, A Jovanovic, E Sudar-Milovanovic, ... Nitric Oxide 54, 51-59, 2016 | 37 | 2016 |
| A review of the cardiovascular and anti-atherogenic effects of ghrelin M Rizzo, AA Rizvi, E Sudar, S Soskic, M Obradovic, G Montalto, M Boutjdir, ... Current Pharmaceutical Design 19 (27), 4953-4963, 2013 | 37 | 2013 |
| Regulation of nitric oxide production in hypothyroidism ZM Gluvic, MM Obradovic, EM Sudar-Milovanovic, SS Zafirovic, DJ Radak, ... Biomedicine & Pharmacotherapy 124, 109881, 2020 | 35 | 2020 |
| Natural and anthropogenic radioactivity of feedstuffs, mosses and soil in the Belgrade environment, Serbia S Grdović, G Vitorović, B Mitrović, V Andrić, B Petrujkić, M Obradović Archives of biological sciences 62 (2), 301-307, 2010 | 35 | 2010 |
| Thrombin stimulates VSMC proliferation through an EGFR-dependent pathway: involvement of MMP-2 K Smiljanic, M Obradovic, A Jovanovic, J Djordjevic, B Dobutovic, ... Molecular and Cellular Biochemistry 396, 147-160, 2014 | 33 | 2014 |
| In vivo effects of 17β-estradiol on cardiac Na+/K+-ATPase expression and activity in rat heart M Obradovic, AJ Stewart, SJ Pitt, M Labudovic-Borovic, E Sudar, ... Molecular and Cellular Endocrinology 388 (1-2), 58-68, 2014 | 33 | 2014 |
| Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases MM Obradović, P Bjelogrlic, M Rizzo, N Katsiki, MA Haidara, AJ Stewart, ... Journal of Endocrinology 218 (3), R13-R23, 2013 | 33 | 2013 |
| Effects of IGF-1 on the cardiovascular system M Obradovic, S Zafirovic, S Soskic, J Stanimirovic, A Trpkovic, ... Current Pharmaceutical Design 25 (35), 3715-3725, 2019 | 32 | 2019 |
